Topical pharmacotherapies offer the unique advantage that the products are applied directly to the diseased skin, resulting in local, distinctly direct contact between the product and the affected skin. The choice of vehicle depends on the type of dermatosis. Vehicle polarity and vehicle viscosity result in optimal contact between the vehicle and affected skin, allowing uncomplicated application and distribution of the product.
Autoren
- Prof. Dr. phil. nat. Christian Surber
Publikation
- DERMATOLOGIE PRAXIS
Related Topics
You May Also Like
- IBDmatters - Synergy effects for IBD pathways
How combination therapies lead to better treatment results
- Focus on prevention
Colorectal cancer screening – an update
- Chronic hand eczema
Topical pan-JAK-i vs. systemic retinoid: head-to-head study
- Study report
Long-term data on CFTR modulators in children with cystic fibrosis
- Multiple sclerosis
Multiple sclerosis 2025: New strategies against progression and the role of microglia
- A syndrome between decompensation and chronification
Worsening Heart Failure
- Actinic keratosis